Mode
Text Size
Log in / Sign up
N/A N=60 Supportive Care

Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring

High Risk Pregnancy

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Number of Interpretable Results (Participants Who Used the NST Device Correctly) — 107; 1 Remote NST's Completed — p=.1

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
In-Home Non-Stress Test Device (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University of Utah
Primary completion
May 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Interpretable Results (Participants Who Used the NST Device Correctly)
107; 1 .1
SECONDARY
Provider Satisfaction With Remote NST Compared to On-site NST
21 <0.01 sig

Summary

Non-stress tests (NSTs) are used to monitor the health of babies during pregnancy. These tests are currently conducted in clinics and hospitals. This requires travel to a clinic or hospital, sometimes multiple times per week, in order to receive these tests. Technology has been developed that now allows for NSTs to be done in other locations, including home or work. The Airstrip® Sense4Baby™ NST device has been FDA-approved for use by obstetricians in clinical and hospital settings. The investigators are evaluating the use of the Airstrip® Sense4Baby™ NST device in out-of-hospital settings. The investigators would like to know if this type of monitoring is feasible and acceptable to patients and physicians.

Eligibility Criteria

Target population: The target population is high-risk pregnant women.

Accessible population: The accessible population is high-risk obstetric patients receiving care throughout the University of Utah Healthcare system and who receive their NSTs at MFDC.

Inclusion Criteria (Phase I):

  • Singleton gestation
  • Estimated gestational age of 32 0/7 -37 6/7 weeks
  • Physician order for twice weekly NSTs
  • Live within 60-mile radius of the University of Utah University Hospital
  • Reliable access to and connectivity with wireless Internet
  • Reliable for communication and follow-up

Exclusion Criteria (Phase I:

  • Multifetal gestation
  • Maternal age less than 18
  • Plans to move prior to end of pregnancy
  • No or limited access to internet and/or phone

Inclusion Criteria (Phase II):

  • Singleton gestation
  • Estimated gestational age of 32 0/7 -37 6/7 weeks
  • Physician order for twice weekly NSTs
  • Live within 60-mile radius of the University of Utah University Hospital or a hospital with an obstetric inpatient unit
  • Reliable access to and connectivity with wireless Internet
  • Reliable for communication and follow-up

Exclusion Criteria (Phase II):

  • Multifetal gestation
  • Maternal age less than 18
  • Plans to move prior to end of pregnancy
  • No or limited access to internet and/or phone
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02379351). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search